Why Aridis Pharmaceuticals Shares Are Soaring Today
Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) shares popped over 100% Wednesday afternoon after the company announced it received an agreement from the FDA on a single confirmatory Phase 3 study of AR-301.